A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of topiramate in the treatment of obese, type 2 diabetic patients treated with metformin
Phase of Trial: Phase III
Latest Information Update: 06 Apr 2010
At a glance
- Drugs Topiramate (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 Apr 2010 Actual patient number (644) added as reported by ClinicalTrials.gov.
- 13 Nov 2005 New trial record.